| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2000 | CN1243123A Photochemical method |
| 02/02/2000 | CN1242997A Markless burn ointment |
| 02/02/2000 | CN1242989A Chitin health-care product and preparation method thereof |
| 02/02/2000 | CN1242988A Medicine composition for treating spirobacillus infection of pylorus |
| 02/02/2000 | CN1242987A Qilaxitong preparation |
| 02/02/2000 | CN1242986A Use of B magnesium tanphenolate in pharmacy |
| 02/02/2000 | CN1242985A Compounded calcium preparation, preparing method and use thereof |
| 02/02/2000 | CN1242984A 4,4-diaryl butadienes compound as water soluble non-photosensitive ultraviolet-ray filtering agent used in cosmetics and medicinal preparation |
| 02/02/2000 | CN1242981A Washing cosmetic composition and use thereof |
| 02/02/2000 | CN1048986C Heterocyclic compounds and their preparation and use |
| 02/02/2000 | CN1048985C Piperazine derivatives as 5HT1A antagonists |
| 02/02/2000 | CN1048983C Preparation of new initiator of taxane derivative and its use |
| 02/02/2000 | CN1048982C Method for semi-synthesis of taxalkane derivative with metal alkane oxide and beta-lactum |
| 02/02/2000 | CN1048893C Medicinal oil for treating hyperosteogeny and preparation method thereof |
| 02/02/2000 | CN1048879C Medicine for treating primary glomerular disease and chyluria, and its preparation method thereof |
| 02/02/2000 | CN1048876C Gum for improving eye sight |
| 02/02/2000 | CN1048870C Praziquantel skin-smearing tissue for schistosomisasis prevention and cure |
| 02/02/2000 | CN1048869C Multi-effect contraceptive liquid |
| 02/02/2000 | CN1048868C Cod-liver oil emulsion and its preparation method |
| 02/01/2000 | USRE36547 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/2000 | US6020513 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 02/01/2000 | US6020510 Cytoprotective compounds |
| 02/01/2000 | US6020492 Deazapurine derivatives; a new class of CRF1 specific ligands |
| 02/01/2000 | US6020488 Small molecule inhibition of RNA/ligand binding |
| 02/01/2000 | US6020487 Intermediates and process for preparing olanzapine |
| 02/01/2000 | US6020469 Freeze drying (lyophilization) is considered useful and effective for preservation of many biologically active materials. |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020383 Administering tert-butylhydroquinone |
| 02/01/2000 | US6020382 Method of treating diabetes and related disease states |
| 02/01/2000 | US6020381 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of protozoan infections |
| 02/01/2000 | US6020380 Respiratory system disorders; administering7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenyl heptanoic acid |
| 02/01/2000 | US6020379 Controlled killing cancer cells |
| 02/01/2000 | US6020378 Method for selectively altering body fat level, feed efficiently, or weight gain |
| 02/01/2000 | US6020377 Modified tall oil supplemented diet for growing-finishing pigs |
| 02/01/2000 | US6020376 Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations |
| 02/01/2000 | US6020374 Biologically active synthetic dye compounds |
| 02/01/2000 | US6020372 Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders |
| 02/01/2000 | US6020371 Antipicornaviral compounds compositions containing them and methods for their use |
| 02/01/2000 | US6020370 Bridged cyclic amino acids as pharmaceutical agents |
| 02/01/2000 | US6020369 Aerosol spray |
| 02/01/2000 | US6020368 Microbiocides |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020365 Anticancer agents; antitumor agents |
| 02/01/2000 | US6020363 Isocoumarin derivatives and use thereof in drugs |
| 02/01/2000 | US6020362 Glycoprotein IIB IIIA antagonists |
| 02/01/2000 | US6020361 Substituted benzo[1,4]dioxines as antiobesity agents |
| 02/01/2000 | US6020360 Anticancer property of dithiolopyrrolones |
| 02/01/2000 | US6020359 Injectable solution of 3-(2-(phenylcarbamoyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid; glycine antagonist |
| 02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020353 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide |
| 02/01/2000 | US6020352 Treatment of ischemic disorders of the retina and optic nerve head |
| 02/01/2000 | US6020351 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/01/2000 | US6020350 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020348 Endothelin receptor antagonists |
| 02/01/2000 | US6020346 Piperidine derivatives having tachykinin antagonist activity |
| 02/01/2000 | US6020345 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 02/01/2000 | US6020342 Fused imidazo[1,2-A]pyridines |
| 02/01/2000 | US6020340 Imidazopyridines |
| 02/01/2000 | US6020339 Aryl furan derivatives as PDE IV inhibitors |
| 02/01/2000 | US6020336 Indole and indazole compounds |
| 02/01/2000 | US6020335 (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 02/01/2000 | US6020333 Compositions containing in particular, riboflavin, for the local prevention of diseases of the genital and rectal mucus membranes |
| 02/01/2000 | US6020331 β-sheet mimetics and use thereof as protease inhibitors |
| 02/01/2000 | US6020330 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/01/2000 | US6020328 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 02/01/2000 | US6020327 Control of hair growth |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020325 Method for inhibiting replication of HIV |
| 02/01/2000 | US6020323 Compositions and methods for regulation of active TNF-α |
| 02/01/2000 | US6020321 Adenosine receptor agonists for the promotion of wound healing |
| 02/01/2000 | US6020320 Acyl deoxyribonucleoside derivatives and uses thereof |
| 02/01/2000 | US6020317 Glycerol derivative, device and pharmaceutical composition |
| 02/01/2000 | US6020315 Preparation having increased in vivo tolerability |
| 02/01/2000 | US6020310 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 02/01/2000 | US6020308 Methods for improving therapeutic effectiveness of treatment of vascularization disorders |
| 02/01/2000 | US6020199 Antisense modulation of PTEN expression |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020172 Nucleic acid delivery with ovine adenoviral vectors |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020139 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 02/01/2000 | US6020135 Monitoring expression of these genes is used to provide indications of p53 status in a cell. such monitoring can also be used to screen for useful anti-cancer therapeutics, as well as for substances which are carcinogenic. |
| 02/01/2000 | US6020121 Screening for an inhibitor of a global regulator of pathogenesis genes |
| 02/01/2000 | US6020007 Pyruvate, d-beta-hydroxybutyrate and acetoacetate anions are the only monoanionic organic metabolic anions present |
| 02/01/2000 | US6020006 Reduction of hair growth |
| 02/01/2000 | US6020003 Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin |
| 02/01/2000 | US6020001 Compositions for treating migraine |
| 02/01/2000 | US6019994 Use of levobupivacaine in treating migraine |
| 02/01/2000 | US6019986 Parasiticidal pyrazoles |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019976 Formulations for treating male pattern baldness containing Serenoa repens, Vitamin B6, Vitamin B3, zinc and L-Arginine |
| 02/01/2000 | US6019968 Dispersible antibody compositions and methods for their preparation and use |
| 02/01/2000 | US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
| 02/01/2000 | US6019104 Method for the treatment or prevention of restenosis associated with coronary intervention |